Run-to-Run algorithm for clinical decision support: In silico study for a personalized adaptation of the basal-bolus therapy and of the visit scheduling

[1]  R. Hovorka,et al.  New closed-loop insulin systems , 2021, Diabetologia.

[2]  Standards of Medical Care in Diabetes—2021 Abridged for Primary Care Providers , 2020, Clinical Diabetes.

[3]  M. Phillip,et al.  Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes , 2020, Nature Medicine.

[4]  Eyal Dassau,et al.  Using Iterative Learning for Insulin Dosage Optimization in Multiple-Daily-Injections Therapy for People With Type 1 Diabetes , 2020, IEEE Transactions on Biomedical Engineering.

[5]  M. Phillip,et al.  Insulin Pump Therapy. , 2020 .

[6]  Claudio Cobelli,et al.  Physiology-Based Run-to-Run Adaptation of Insulin to Carbohydrate Ratio Improves Type 1 Diabetes Therapy: Results from an In Silico Study , 2019, 2019 American Control Conference (ACC).

[7]  V. Renée,et al.  The lived experience of continuous subcutaneous insulin infusion in adults with Type 1 Diabetes Mellitus: a phenomenological inquiry , 2019 .

[8]  D. Kruger,et al.  Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial , 2019, The Lancet.

[9]  Tao Zhang,et al.  A survey of run-to-run control for batch processes. , 2018, ISA transactions.

[10]  I. Hirsch,et al.  Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring , 2018, Diabetes Care.

[11]  E. Dassau,et al.  Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians , 2018, Diabetes, obesity & metabolism.

[12]  D. Klonoff,et al.  Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital , 2018, Journal of diabetes science and technology.

[13]  Claudio Cobelli,et al.  Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results , 2018, IEEE Transactions on Biomedical Engineering.

[14]  Pantelis Georgiou,et al.  Automatic Adaptation of Basal Insulin Using Sensor-Augmented Pump Therapy , 2018, Journal of diabetes science and technology.

[15]  Claudio Cobelli,et al.  The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day , 2018, Journal of diabetes science and technology.

[16]  B. Kovatchev.  The artificial pancreas in 2017: The year of transition from research to clinical practice , 2018, Nature Reviews Endocrinology.

[17]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[18]  R. Corcoy,et al.  Evaluation of a New Digital Automated Glycemic Pattern Detection Tool , 2017, Diabetes technology & therapeutics.

[19]  Claudio Cobelli,et al.  Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions , 2017 .

[20]  Christofer Toumazou,et al.  Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability , 2017, Comput. Methods Programs Biomed..

[21]  Howard C. Zisser,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[22]  Claudio Cobelli,et al.  2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. , 2015, The lancet. Diabetes & endocrinology.

[23]  S. Wild,et al.  Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[24]  Dong Shen,et al.  Optimization of insulin pump therapy based on high order run-to-run control scheme , 2015, Comput. Methods Programs Biomed..

[25]  David M Maahs,et al.  Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry , 2015, Diabetes Care.

[26]  Christofer Toumazou,et al.  Advanced Insulin Bolus Advisor Based on Run-To-Run Control and Case-Based Reasoning , 2015, IEEE Journal of Biomedical and Health Informatics.

[27]  S. Shalitin,et al.  Using the Internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes , 2014, Acta Diabetologica.

[28]  Claudio Cobelli,et al.  Artificial Pancreas: Model Predictive Control Design from Clinical Experience , 2013, Journal of diabetes science and technology.

[29]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[30]  Giuseppe De Nicolao,et al.  MPC based Artificial Pancreas: Strategies for individualization and meal compensation , 2012, Annu. Rev. Control..

[31]  Guido Freckmann,et al.  Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison. , 2010, Diabetes technology & therapeutics.

[32]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[33]  Jeanette S. Andrews,et al.  Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. , 2009, The Journal of pediatrics.

[34]  M. Davidson.  How Our Current Medical Care System Fails People With Diabetes , 2009, Diabetes Care.

[35]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[36]  Francis J. Doyle,et al.  A run‐to‐run framework for prandial insulin dosing: handling real‐life uncertainty , 2007 .

[37]  Howard C. Zisser,et al.  Prandial Insulin Dosing Using Run-to-Run Control , 2007, Diabetes Care.

[38]  Francis J. Doyle,et al.  Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus , 2006, IEEE Transactions on Biomedical Engineering.

[39]  H. Zisser,et al.  Run-to-run control of meal-related insulin dosing. , 2005, Diabetes technology & therapeutics.

[40]  J. Weissberg-Benchell,et al.  Insulin pump therapy: a meta-analysis. , 2003, Diabetes care.

[41]  Francis J. Doyle,et al.  Run-to-run control strategy for diabetes management , 2001, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[42]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[43]  The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility Phase , 1986, Diabetes.

[44]  Claudio Cobelli,et al.  Automatic adaptation of basal therapy for Type 1 diabetic patients: A Run-to-Run approach , 2017, Biomed. Signal Process. Control..